menu
    • menu

    Company profile for Lupus Therapeutics

    NEW Drugs in Dev: 3
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lupus Therapeutics was established to advance lupus clinical research by finding more effective and safer treatments for people living with lupus. In well over half a century only one new drug has been approved to treat this disease; this is not good enough. We are committed to finding and illuminating promising new treatment opportunities, and ultimately delivering them to lupus patients in just years, not decades.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lupus TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    275 Madison Avenue, 10th Floor New York, NY 10016
    Telephone
    Telephone
    800-867-1743
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lupusresearch.org/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lupus drug market growing as physicians adopt newer options — and look for more
    Lupus drug market growing as physicians adopt newer options — and look for more

    09 Jan 2024

    // Beth Snyder Bulik ENDPTS

    https://endpts.com/lupus-drug-market-growing-as-physicians-adopt-newer-options-and-look-for-more-research-finds/

    Beth Snyder Bulik ENDPTS
    09 Jan 2024
    Share Share
    Lupus Therapeutics, AbbVie partner for trials of SLE therapy
    Lupus Therapeutics, AbbVie partner for trials of SLE therapy

    26 Oct 2023

    // Joseph Keenan FIERCE BIOTECH

    https://www.fiercebiotech.com/cro/lupus-therapeutics-abbvie-partner-phase-3-trials-upadacitinib-sle-therapy

    Joseph Keenan FIERCE BIOTECH
    26 Oct 2023
    Share Share
    Lupus Therapeutics Partners with AbbVie on Clinical Trial Recruitment
    Lupus Therapeutics Partners with AbbVie on Clinical Trial Recruitment

    24 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lupus-therapeutics-partners-with-abbvie-on-clinical-trial-recruitment-efforts-in-sle-through-lucin-lupus-clinical-trial-network-301964999.html

    PR NEWSWIRE
    24 Oct 2023
    Share Share
    Lupus Therapeutics Partners to Evaluate Potential Treatment for SLE
    Lupus Therapeutics Partners to Evaluate Potential Treatment for SLE

    02 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lupus-therapeutics-partners-to-evaluate-potential-treatment-for-sle-and-lupus-nephritis-through-north-american-trial-network-301841208.html

    PR NEWSWIRE
    02 Jun 2023
    Share Share
    Lupus Research Alliance Announces Four New Recipients of the Lupus
    Lupus Research Alliance Announces Four New Recipients of the Lupus

    20 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lupus-research-alliance-announces-four-new-recipients-of-the-lupus-mechanisms-and-targets-award-301803361.html

    PR NEWSWIRE
    20 Apr 2023
    Share Share
    Lupus Research Alliance and Lupus Tx Response to Positive Data from PII Study
    Lupus Research Alliance and Lupus Tx Response to Positive Data from PII Study

    01 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lupus-research-alliance-and-lupus-therapeutics-response-to-positive-data-from-phase-2-study-on-potential-first-in-class-lupus-treatment-301558822.html

    PRNEWSWIRE
    01 Jun 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search